{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T16:44:36Z","timestamp":1788021876956,"version":"build-2784847793"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T00:00:00Z","timestamp":1752883200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T00:00:00Z","timestamp":1752883200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"VHRN"},{"DOI":"10.13039\/501100000156","name":"FRQS","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Ocular Oncology Research Fund, Dr. Christine Corriveau, Department of Ophthalmology, University of Montreal"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>uveal melanoma (UM) is the most common primary intraocular tumor in adults, with metastasis being the leading cause of death. However, effective treatments for metastatic UM remain limited. Emerging evidence suggests that cholesterol metabolism plays a role in cancer progression, but its impact on UM metastasis is not well understood.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>we investigated the effects of miR-181a on UM metastasis using multiple UM cell lines and a suprachoroidal injection mouse model. Functional assays, including migration, invasion, and cancer stem-like cell (CSC) formation, were performed. The target of miR-181a was identified through bioinformatics, luciferase assays, and western blotting. Cholesterol levels were measured, and in vitro and in vivo studies assessed the therapeutic potential of combining miR-181a with crizotinib.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>miR-181a significantly decreases UM cell migration, invasion, and metastasis. Mechanistically, miR-181a was found to target sterol regulatory element-binding protein 2 (SREBP2), thereby inhibiting cholesterol biosynthesis. This decrease in cholesterol levels hindered reduced epithelial-to-mesenchymal transition (EMT) and led to a decline in cancer stem-like cell (CSC) populations in UM. Furthermore, elevated cholesterol or overexpression of SREBP2 abrogated the anti-metastatic effects of miR-181a. Additionally, a combination of miR-181a and crizotinib significantly inhibited metastasis, both in vitro and in vivo.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>miR-181a inhibits UM metastasis by targeting SREBP2 and reducing cholesterol biosynthesis. Its combination with crizotinib may provide a promising therapeutic strategy for metastatic UM.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13046-025-03459-8","type":"journal-article","created":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T04:04:06Z","timestamp":1752897846000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["MiR-181a-driven downregulation of cholesterol biosynthesis through SREBP2 inhibition suppresses uveal melanoma metastasis"],"prefix":"10.1186","volume":"44","author":[{"given":"Rui","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houda","family":"Tahiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solange","family":"Landreville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Hardy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,19]]},"reference":[{"key":"3459_CR1","doi-asserted-by":"crossref","unstructured":"Sorrentino FS et al. Genetic features of uveal melanoma. Genes (Basel) 2024;15(11).","DOI":"10.3390\/genes15111356"},{"key":"3459_CR2","doi-asserted-by":"crossref","unstructured":"Kulbay M et al. Uveal melanoma: comprehensive review of its pathophysiology, diagnosis, treatment, and future perspectives. Biomedicines 2024;12(8).","DOI":"10.3390\/biomedicines12081758"},{"issue":"3","key":"3459_CR3","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1097\/ICU.0000000000000051","volume":"25","author":"MG Field","year":"2014","unstructured":"Field MG, Harbour JW. Recent developments in prognostic and predictive testing in uveal melanoma. Curr Opin Ophthalmol. 2014;25(3):234\u20139.","journal-title":"Curr Opin Ophthalmol"},{"key":"3459_CR4","doi-asserted-by":"crossref","unstructured":"Fuentes-Rodriguez A et al. Recent advances in molecular and genetic research on uveal melanoma. Cells 2024;13(12).","DOI":"10.3390\/cells13121023"},{"issue":"1","key":"3459_CR5","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ajo.2009.01.023","volume":"148","author":"JJ Augsburger","year":"2009","unstructured":"Augsburger JJ, et al. Effectiveness of treatments for metastatic uveal melanoma. Am J Ophthalmol. 2009;148(1):119\u201327.","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"3459_CR6","first-page":"293","volume":"13","author":"R Wang","year":"2023","unstructured":"Wang R, et al. MiR-181a-5p inhibits uveal melanoma development by targeting GNAQ and AKT3. Am J Cancer Res. 2023;13(1):293\u2013306.","journal-title":"Am J Cancer Res"},{"key":"3459_CR7","doi-asserted-by":"crossref","unstructured":"Liang L, Kaufmann AM. The significance of Cancer stem cells and Epithelial-Mesenchymal transition in metastasis and Anti-Cancer therapy. Int J Mol Sci 2023;24(3).","DOI":"10.3390\/ijms24032555"},{"key":"3459_CR8","first-page":"2973","volume":"8","author":"SS Wang","year":"2015","unstructured":"Wang SS, et al. Links between cancer stem cells and epithelial-mesenchymal transition. Onco Targets Ther. 2015;8:2973\u201380.","journal-title":"Onco Targets Ther"},{"key":"3459_CR9","first-page":"680","volume":"23","author":"C Ness","year":"2017","unstructured":"Ness C, et al. Multicellular tumor spheroids of human uveal melanoma induce genes associated with Anoikis resistance, lipogenesis, and SSXs. Mol Vis. 2017;23:680\u201394.","journal-title":"Mol Vis"},{"issue":"13","key":"3459_CR10","doi-asserted-by":"publisher","first-page":"3927","DOI":"10.1016\/j.celrep.2019.05.104","volume":"27","author":"S Ehmsen","year":"2019","unstructured":"Ehmsen S, et al. Increased cholesterol biosynthesis is a key characteristic of breast Cancer stem cells influencing patient outcome. Cell Rep. 2019;27(13):3927\u2013e39383926.","journal-title":"Cell Rep"},{"issue":"1","key":"3459_CR11","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/s41467-017-00910-z","volume":"8","author":"AE Baek","year":"2017","unstructured":"Baek AE, et al. The cholesterol metabolite 27 hydroxycholesterol facilitates breast cancer metastasis through its actions on immune cells. Nat Commun. 2017;8(1):864.","journal-title":"Nat Commun"},{"issue":"8","key":"3459_CR12","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1111\/cas.15435","volume":"113","author":"T He","year":"2022","unstructured":"He T, et al. 27-Hydroxycholesterol promotes metastasis by SULT2A1-dependent alteration in hepatocellular carcinoma. Cancer Sci. 2022;113(8):2575\u201389.","journal-title":"Cancer Sci"},{"issue":"6","key":"3459_CR13","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1158\/1541-7786.MCR-17-0665","volume":"16","author":"HJ Lee","year":"2018","unstructured":"Lee HJ, et al. Cholesterol esterification Inhibition suppresses prostate Cancer metastasis by impairing the Wnt\/\u03b2-catenin pathway. Mol Cancer Res. 2018;16(6):974\u201385.","journal-title":"Mol Cancer Res"},{"issue":"6","key":"3459_CR14","doi-asserted-by":"publisher","first-page":"101043","DOI":"10.1016\/j.tranon.2021.101043","volume":"14","author":"SS Mayengbam","year":"2021","unstructured":"Mayengbam SS, et al. Influence of cholesterol on cancer progression and therapy. Transl Oncol. 2021;14(6):101043.","journal-title":"Transl Oncol"},{"key":"3459_CR15","doi-asserted-by":"publisher","first-page":"8801","DOI":"10.1038\/srep08801","volume":"5","author":"B Chu","year":"2015","unstructured":"Chu B, et al. MiR-181a regulates lipid metabolism via IDH1. Sci Rep. 2015;5:8801.","journal-title":"Sci Rep"},{"key":"3459_CR16","doi-asserted-by":"crossref","unstructured":"Alexandrova E et al. Small Non-Coding RNA profiling identifies miR-181a-5p as a mediator of Estrogen receptor Beta-Induced Inhibition of cholesterol biosynthesis in Triple-Negative breast Cancer. Cells 2020;9(4).","DOI":"10.3390\/cells9040874"},{"issue":"4","key":"3459_CR17","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41580-019-0190-7","volume":"21","author":"J Luo","year":"2020","unstructured":"Luo J, et al. Mechanisms and regulation of cholesterol homeostasis. Nat Rev Mol Cell Biol. 2020;21(4):225\u201345.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"11","key":"3459_CR18","doi-asserted-by":"publisher","first-page":"12869","DOI":"10.18632\/oncotarget.7331","volume":"7","author":"X Li","year":"2016","unstructured":"Li X, et al. SREBP-2 promotes stem cell-like properties and metastasis by transcriptional activation of c-Myc in prostate cancer. Oncotarget. 2016;7(11):12869\u201384.","journal-title":"Oncotarget"},{"issue":"9","key":"3459_CR19","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1007\/s00018-022-04504-x","volume":"79","author":"M Wei","year":"2022","unstructured":"Wei M, et al. Unspliced XBP1 contributes to cholesterol biosynthesis and tumorigenesis by stabilizing SREBP2 in hepatocellular carcinoma. Cell Mol Life Sci. 2022;79(9):472.","journal-title":"Cell Mol Life Sci"},{"issue":"4","key":"3459_CR20","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3390\/biomedicines2040301","volume":"2","author":"O Mungunsukh","year":"2014","unstructured":"Mungunsukh O, et al. Hepatocyte growth factor isoforms in tissue repair, cancer, and fibrotic remodeling. Biomedicines. 2014;2(4):301\u201326.","journal-title":"Biomedicines"},{"issue":"3","key":"3459_CR21","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1080\/02713680601161220","volume":"32","author":"K Mallikarjuna","year":"2007","unstructured":"Mallikarjuna K, et al. Expression of epidermal growth factor receptor, ezrin, hepatocyte growth factor, and c-Met in uveal melanoma: an immunohistochemical study. Curr Eye Res. 2007;32(3):281\u201390.","journal-title":"Curr Eye Res"},{"issue":"12","key":"3459_CR22","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1158\/1535-7163.MCT-13-0499","volume":"12","author":"O Surriga","year":"2013","unstructured":"Surriga O, et al. Crizotinib, a c-Met inhibitor, prevents metastasis in a metastatic uveal melanoma model. Mol Cancer Ther. 2013;12(12):2817\u201326.","journal-title":"Mol Cancer Ther"},{"key":"3459_CR23","unstructured":"Jager MJ et al. Uveal Melanoma Cell Lines: Where do they come from? (An American Ophthalmological Society Thesis). Trans Am Ophthalmol Soc. 2016;114(T5)."},{"issue":"3","key":"3459_CR24","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1158\/1535-7163.MCT-16-0552","volume":"16","author":"H Cheng","year":"2017","unstructured":"Cheng H, et al. Co-targeting hgf\/cmet signaling with MEK inhibitors in metastatic uveal melanoma. Mol Cancer Ther. 2017;16(3):516\u201328.","journal-title":"Mol Cancer Ther"},{"issue":"4","key":"3459_CR25","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1097\/00008390-200508000-00005","volume":"15","author":"S Labialle","year":"2005","unstructured":"Labialle S, et al. Characterization of the typical multidrug resistance profile in human uveal melanoma cell lines and in mouse liver metastasis derivatives. Melanoma Res. 2005;15(4):257\u201366.","journal-title":"Melanoma Res"},{"issue":"8","key":"3459_CR26","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1167\/iovs.65.8.37","volume":"65","author":"MC Gelmi","year":"2024","unstructured":"Gelmi MC, et al. Protein and mRNA expression in uveal melanoma cell lines are related to GNA and BAP1 mutation status. Invest Ophthalmol Vis Sci. 2024;65(8):37.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"3459_CR27","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1006\/exer.1996.0020","volume":"62","author":"KC Dunn","year":"1996","unstructured":"Dunn KC, et al. ARPE-19, a human retinal pigment epithelial cell line with differentiated properties. Exp Eye Res. 1996;62(2):155\u201369.","journal-title":"Exp Eye Res"},{"issue":"1","key":"3459_CR28","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s12943-019-1068-1","volume":"18","author":"J Zhou","year":"2019","unstructured":"Zhou J, et al. Salinomycin effectively eliminates cancer stem-like cells and obviates hepatic metastasis in uveal melanoma. Mol Cancer. 2019;18(1):159.","journal-title":"Mol Cancer"},{"issue":"630","key":"3459_CR29","doi-asserted-by":"publisher","first-page":"eabf5473","DOI":"10.1126\/scitranslmed.abf5473","volume":"14","author":"M Zhang","year":"2022","unstructured":"Zhang M, et al. CECR2 drives breast cancer metastasis by promoting NF-\u03baB signaling and macrophage-mediated immune suppression. Sci Transl Med. 2022;14(630):eabf5473.","journal-title":"Sci Transl Med"},{"key":"3459_CR30","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.pvr.2015.08.001","volume":"1","author":"SH Lee","year":"2015","unstructured":"Lee SH, et al. Human papillomavirus 16 (HPV16) enhances tumor growth and cancer stemness of HPV-negative oral\/oropharyngeal squamous cell carcinoma cells via miR-181 regulation. Papillomavirus Res. 2015;1:116\u201325.","journal-title":"Papillomavirus Res"},{"issue":"10","key":"3459_CR31","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1007\/s00432-021-03684-6","volume":"147","author":"J Liu","year":"2021","unstructured":"Liu J, et al. Human umbilical cord mesenchymal stem cells-derived Exosomal microRNA-181a retards nasopharyngeal carcinoma development by mediating KDM5C. J Cancer Res Clin Oncol. 2021;147(10):2867\u201377.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"2","key":"3459_CR32","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0046-8177(82)80116-0","volume":"13","author":"IW McLean","year":"1982","unstructured":"McLean IW, et al. Uveal melanoma: location, size, cell type, and enucleation as risk factors in metastasis. Hum Pathol. 1982;13(2):123\u201332.","journal-title":"Hum Pathol"},{"issue":"11","key":"3459_CR33","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1136\/bjophthalmol-2015-306810","volume":"99","author":"MT Andreoli","year":"2015","unstructured":"Andreoli MT, et al. Epidemiological trends in uveal melanoma. Br J Ophthalmol. 2015;99(11):1550\u20133.","journal-title":"Br J Ophthalmol"},{"key":"3459_CR34","doi-asserted-by":"publisher","first-page":"115625","DOI":"10.1016\/j.bcp.2023.115625","volume":"213","author":"B Jin","year":"2023","unstructured":"Jin B, et al. Ferroptosis induced by DCPS depletion diminishes hepatic metastasis in uveal melanoma. Biochem Pharmacol. 2023;213:115625.","journal-title":"Biochem Pharmacol"},{"key":"3459_CR35","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1186\/1471-2407-13-371","volume":"13","author":"KA Matatall","year":"2013","unstructured":"Matatall KA, et al. BAP1 deficiency causes loss of melanocytic cell identity in uveal melanoma. BMC Cancer. 2013;13:371.","journal-title":"BMC Cancer"},{"issue":"21","key":"3459_CR36","first-page":"e2594","volume":"7","author":"Y Chen","year":"2017","unstructured":"Chen Y, et al. Xenograft mouse model of human uveal melanoma. Bio Protoc. 2017;7(21):e2594.","journal-title":"Bio Protoc"},{"issue":"1","key":"3459_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/CMR.0000000000000860","volume":"33","author":"R Ramos","year":"2023","unstructured":"Ramos R, et al. Orthotopic murine xenograft model of uveal melanoma with spontaneous liver metastasis. Melanoma Res. 2023;33(1):1\u201311.","journal-title":"Melanoma Res"},{"issue":"12","key":"3459_CR38","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1001\/archopht.123.12.1639","volume":"123","author":"M Diener-West","year":"2005","unstructured":"Diener-West M, et al. Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: collaborative ocular melanoma study group report 26. Arch Ophthalmol. 2005;123(12):1639\u201343.","journal-title":"Arch Ophthalmol"},{"key":"3459_CR39","first-page":"919","volume":"21","author":"L Asnaghi","year":"2015","unstructured":"Asnaghi L, et al. EMT-associated factors promote invasive properties of uveal melanoma cells. Mol Vis. 2015;21:919\u201329.","journal-title":"Mol Vis"},{"issue":"15","key":"3459_CR40","doi-asserted-by":"publisher","first-page":"3741","DOI":"10.1158\/1078-0432.CCR-17-1703","volume":"24","author":"Y Jin","year":"2018","unstructured":"Jin Y, et al. Neddylation Blockade diminishes hepatic metastasis by dampening Cancer Stem-Like cells and angiogenesis in uveal melanoma. Clin Cancer Res. 2018;24(15):3741\u201354.","journal-title":"Clin Cancer Res"},{"key":"3459_CR41","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.canlet.2017.04.028","volume":"400","author":"Y Wang","year":"2017","unstructured":"Wang Y, et al. In vitro and in vivo anti-uveal melanoma activity of JSL-1, a novel HDAC inhibitor. Cancer Lett. 2017;400:47\u201360.","journal-title":"Cancer Lett"},{"issue":"6","key":"3459_CR42","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.7150\/thno.17451","volume":"7","author":"J Zhou","year":"2017","unstructured":"Zhou J, et al. The antihelminthic drug niclosamide effectively inhibits the malignant phenotypes of uveal melanoma in vitro and in vivo. Theranostics. 2017;7(6):1447\u201362.","journal-title":"Theranostics"},{"issue":"9","key":"3459_CR43","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1002\/1878-0261.13180","volume":"16","author":"JW Park","year":"2022","unstructured":"Park JW, et al. Autophagy inhibits cancer stemness in triple-negative breast cancer via miR-181a-mediated regulation of ATG5 and\/or ATG2B. Mol Oncol. 2022;16(9):1857\u201375.","journal-title":"Mol Oncol"},{"key":"3459_CR44","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.3389\/fonc.2020.01510","volume":"10","author":"L Xue","year":"2020","unstructured":"Xue L, et al. Targeting SREBP-2-Regulated mevalonate metabolism for Cancer therapy. Front Oncol. 2020;10:1510.","journal-title":"Front Oncol"},{"key":"3459_CR45","doi-asserted-by":"publisher","first-page":"976837","DOI":"10.3389\/fonc.2022.976837","volume":"12","author":"S Khan","year":"2022","unstructured":"Khan S, et al. Adjuvant Crizotinib in high-risk uveal melanoma following definitive therapy. Front Oncol. 2022;12:976837.","journal-title":"Front Oncol"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-025-03459-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-025-03459-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-025-03459-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T14:55:37Z","timestamp":1757256937000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-025-03459-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,19]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3459"],"URL":"https:\/\/doi.org\/10.1186\/s13046-025-03459-8","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,19]]},"assertion":[{"value":"20 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Our study was approved by the CHU Sainte-Justine Animal Care Committee (Protocol 2021\u20132820).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"215"}}